Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Work In Process (2016 - 2017)

Historic Work In Process for Vanda Pharmaceuticals (VNDA) over the last 4 years, with Q4 2017 value amounting to $80000.0.

  • Vanda Pharmaceuticals' Work In Process rose 37058.82% to $80000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $80000.0, marking a year-over-year increase of 37058.82%. This contributed to the annual value of $80000.0 for FY2017, which is 37058.82% up from last year.
  • Vanda Pharmaceuticals' Work In Process amounted to $80000.0 in Q4 2017, which was up 37058.82% from $63000.0 recorded in Q3 2017.
  • In the past 5 years, Vanda Pharmaceuticals' Work In Process registered a high of $1.8 million during Q2 2015, and its lowest value of $7000.0 during Q2 2014.
  • Its 4-year average for Work In Process is $564833.3, with a median of $71500.0 in 2017.
  • As far as peak fluctuations go, Vanda Pharmaceuticals' Work In Process soared by 2530000.0% in 2015, and later skyrocketed by 37058.82% in 2017.
  • Over the past 4 years, Vanda Pharmaceuticals' Work In Process (Quarter) stood at $1.3 million in 2014, then rose by 19.0% to $1.6 million in 2015, then tumbled by 98.92% to $17000.0 in 2016, then skyrocketed by 370.59% to $80000.0 in 2017.
  • Its last three reported values are $80000.0 in Q4 2017, $63000.0 for Q3 2017, and $131000.0 during Q2 2017.